| NCT06577090 | Study to Evaluate the Effect on Obesity of Once Weekly Nimacimab Injection and Once Weekly Nimacimab Injection Co-administered With Semaglutide Injection Versus Placebo | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-08-22 | 2026-01 | 2025-08 |
| NCT06144918 | Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure | COMPLETED | PHASE2 | 2023-11-09 | 2024-02-22 | 2024-02-22 |
| NCT02335515 | The Gastric Residence Time (GRT) of Soctec Capsule After a Standardized Breakfast | UNKNOWN | EARLY_PHASE1 | 2014-09 | 2015-03 | 2014-10 |
| NCT00747318 | A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005 | COMPLETED | PHASE3 | 2008-09 | 2010-06 | 2010-05 |
| NCT00734292 | Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma | COMPLETED | PHASE2 | 2008-09 | 2008-10 | 2008-09 |
| NCT00657774 | A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiFormâ„¢ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands | COMPLETED | PHASE1 | 2008-04 | 2008-09 | 2008-09 |
| NCT00649025 | A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiFormâ„¢) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults | COMPLETED | PHASE3 | 2008-03 | 2008-10 | 2008-10 |
| NCT00393991 | Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma | COMPLETED | PHASE3 | 2006-07 | 2008-04 | 2008-04 |
| NCT00394199 | Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma | COMPLETED | PHASE3 | 2006-06 | 2008-02 | 2008-02 |
| NCT00393952 | New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma | COMPLETED | PHASE3 | 2006-06 | 2008-04 | 2008-04 |
| NCT00394121 | New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma | COMPLETED | PHASE3 | 2006-03 | 2007-07 | 2007-07 |
| NCT00830102 | Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients | COMPLETED | PHASE2 | 2004-10 | 2005-01 | 2005-01 |